Jessie Inchauspé describes GLP-1 as a hormone released after eating and claims certain habits could boost it. These claims are hers and unproven here.
Recap by typeshit. Post by @glucosegoddess on Instagram.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Two in vitro studies credited by the company found effects on gut bacteria and satiety hormones. The lead researcher says human trials are still needed.
Sharp looks at whether constant thoughts about food point to a disrupted appetite system or simply a body that needs more fuel.
Loading…